Elucidation of D3 receptor function in vivo: do D3 receptors mediate inhibition of dopamine neuronal activity?
Routledge
C
C
Psychiatry Research Department, SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Harlow, Essex, U.K.
Thorn
L
L
Ashmeade
T
T
Taylor
S
S
D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D003342:Corpus Striatum / Q000187:drug effects / Q000502:physiology*; D004298:Dopamine / Q000378:metabolism*; D018491:Dopamine Agonists / Q000494:pharmacology*; D004873:Ergolines / Q000494:pharmacology; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D017551:Microdialysis; D009474:Neurons / Q000187:drug effects / Q000502:physiology*; D009714:Nucleus Accumbens / Q000187:drug effects / Q000502:physiology*; D010078:Oxazines / Q000494:pharmacology; D011804:Quinolines / Q000494:pharmacology; D019257:Quinpirole; D051381:Rats; D017207:Rats, Sprague-Dawley; D017448:Receptors, Dopamine D2 / Q000187:drug effects / Q000502:physiology*; D050637:Receptors, Dopamine D3; D013764:Tetrahydronaphthalenes / Q000494:pharmacology
D018491:Dopamine Agonists; C493594:Drd3 protein, mouse; C493595:Drd3 protein, rat; D004873:Ergolines; D010078:Oxazines; D011804:Quinolines; D017448:Receptors, Dopamine D2; D050637:Receptors, Dopamine D3; D013764:Tetrahydronaphthalenes; D019257:Quinpirole; C042631:naxagolide; D001058:Apomorphine; C031349:7-hydroxy-2-N,N-dipropylaminotetralin; D004298:Dopamine; C047726:quinelorane